NET PROFIT (x1000 SEK)
Novo Nordisk Region Europe A/S
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
2,455,643
|
360,496
|
0 |
| Total assets |
26,692,589
|
13,716,585
|
0 |
| Current assets |
144,490
|
1,189,514
|
0 |
| Current liabilities |
88,728
|
623,047
|
0 |
| Equity capital |
25,506,862
|
11,619,267
|
0 |
| - share capital |
166,864
|
161,345
|
0 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
95.6%
|
84.7% | |
| Turnover per employee | |||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
162.8%
|
190.9% | |
| Return on equity (ROE) |
9.6%
|
3.1% | |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.